InvestorsObserver
×
News Home

What is the Market's View on Crinetics Pharmaceuticals Inc (CRNX) Stock's Price and Volume Trends Wednesday?

Wednesday, November 15, 2023 11:19 AM | InvestorsObserver Analysts

Mentioned in this article

What is the Market's View on Crinetics Pharmaceuticals Inc (CRNX) Stock's Price and Volume Trends Wednesday?

Crinetics Pharmaceuticals Inc (CRNX) stock is higher by 5.13% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,bullish
Crinetics Pharmaceuticals Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on CRNX!

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With CRNX Stock Today?

Crinetics Pharmaceuticals Inc (CRNX) stock is trading at $29.91 as of 11:19 AM on Wednesday, Nov 15, a gain of $1.26, or 4.4% from the previous closing price of $28.65. The stock has traded between $28.47 and $30.15 so far today. Volume today is less active than usual. So far 180,165 shares have traded compared to average volume of 873,545 shares.

More About Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Click Here to get the full Stock Report for Crinetics Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App